* Sophia Genetics SA SOPH.OQ reported a quarterly adjusted
loss of 31 cents per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 39 cents per share.
* Revenue was $10.18 million; analysts expected $8.60
million.
* Sophia Genetics SA's reported EPS for the quarter was a loss
of 38 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* The company reported a quarterly loss of $18.39 million.
* Wall Street's median 12-month price target for Sophia Genetics
SA is $23.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated September 9 at 12:32 p.m.
All figures in US dollars unless otherwise stated